Wednesday, December 10th, 2025: Day Two - ET (Eastern Time, GMT-05:00)
Discover how new working models are transforming the pharmacy industry
Understand enhanced efficiency and flexibility through remote work models
Improve decision-making and patient care with AI-driven solutions
Gain practical strategies to future-proof pharmacy operations
When launching a new product, designing the right distribution network is critical to success. This session guides participants through the key considerations and decision-making processes involved in creating a network.
Evaluate product usage patterns and special handling requirements before committing to a network design
Understand that not all trade strategies are the same and tailoring your approach accordingly
Build the right team and crafting customized solutions to support your network
Define the scope and performance expectations of your network to ensure it aligns with your goals that meets the unique needs of your product.
- Tami Carten - Vice President of Trade and Patient Support, Braeburn
Gain actionable insights on scenario planning and forecasting methodologies to position your portfolio optimally in the post-IRA landscape
Learn practical approaches to accelerate value creation earlier in product lifecycles and leverage emerging technologies to thrive despite economic constraints
Understand the different navigation pathways for drugs selected for negotiation
- Sopheap Dijhanian - Director, Riparian LLC
Analyze drop-ship versus full-line wholesale distribution approaches, including real-world cost implications, inventory management considerations and impact on patient access
Illuminate the complex interplay between manufacturers, specialty pharmacies, providers and payers
Examine how distribution choices affect each stakeholder differently, from health systems managing limited storage capacity to specialty pharmacies balancing inventory risk
- John Bullock, MBA - Senior Director, Trade, Distribution & GPO, UroGen Pharma
- Charlie Beck - Director, Supply Chain, UroGen Pharma
The landscape of life sciences is rapidly evolving with the increasing adoption of generics and biosimilars. This session equips you with actionable strategies to navigate this competitive environment and achieve sustainable growth.
Delve into the current state of generics and biosimilars adoption, highlighting key trends and market segments with high growth potential
Learn how to effectively position products against competitors, navigate payer negotiations and secure favorable reimbursement decision
Discuss how health systems are approaching generics and biosimilars, and how to tailor approaches to meet evolving needs and priorities
Gain insights into emerging trends and technologies that will shape the future of generics and biosimilars, allowing you to stay ahead of the curve
- Nick Rausch - Vice President of Trade and National Accounts, BioCareSD
- Ryan Cort - Senior Director, Generics & Biosimilars Trade Relations, BioCare, Inc